- Telehealth Visits
- Insurance plan information
Nicholas A. Butowski, MD
Neuro-Oncology- Telehealth Visits
- Insurance plan information
Nicholas A. Butowski, MD
Neuro-Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders. He is director of clinical services in neuro-oncology and a researcher at the Brain Tumor Center.
In his research, Butowski focuses on developing treatments for primary brain tumors as well as methods to ensure good quality of life for patients and to assist them in recovering from or coping with brain injury.
Butowski earned his medical degree at the University of Illinois at Chicago. He completed a residency in neurology and a fellowship in neuro-oncology at UCSF. He is a member of the American Academy of Neurology, American Society of Clinical Oncology and Society for Neuro-oncology.
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neuro-Oncology, UCSF Medical Center - OMAG
Residency
- Neurology, UCSF Medical Center - OMAG
Internship
- Internal Medicine, Evanston Northwestern Healthcare Internal Med Res
Degree
- MD, University of Illinois School of Medicine-Chicago
My expertise
Specialties
Conditions
Locations
My research
Clinical trials
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaOpens in a new window
Recruiting
Overall survival is defined from the time of randomization to death from any cause. Patients still alive at the time of an analysis will be considered…Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesOpens in a new window
Recruiting
The safety and tolerability of AZD9574 as monotherapy and in combination with anti-cancer agents and TMZ in participants with advanced malignancies will be…RMC-5552 Monotherapy in Adult Subjects With Recurrent GlioblastomaOpens in a new window
Recruiting
MTD is defined as the maximal dose at which fewer than one-third of participants experience a dose-limiting toxicity (DLT).
Publications
Showing 1-6 of 59 reviews
- January 27, 20265 out of 5 Stars
The visit went very well, everyone was friendly, courteous and helpful
- January 21, 20265 out of 5 Stars
My comments also apply to Dr. Butowski's supporting team members and staff in Neuro-oncology. A+
- January 15, 20265 out of 5 Stars
Dr Butowski and team are amazing. We are navigating a terrible disease, one that is hopeless, but their care, and thoughtfulness remind us that we are lucky to have this time together, however long/short it is.
- January 8, 20265 out of 5 Stars
Dr B does a great job listening to my concerns and answering my questions. Excellent experience as always.
- December 13, 20255 out of 5 Stars
Nicholas Butowski is an excellent physician, smart and kind.
- November 25, 20255 out of 5 Stars
Exceptional care and proactive follow-up and communications!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.